Ambrisentan Tablet, Film Coated
Product Images NDC 50090-7671

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Ambrisentan (NDC 50090-7671). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ambrisentan-fig1.jpg (Ambrisentan Fig1)

A chart showing the fold change and 90% confidence intervals for various interacting drugs on ambrisentan pharmacokinetics, including Cmax and AUC. Drugs listed include Cyclosporine, Mycophenolate Mofetil, Ketoconazole, Omeprazole, Rifampin, Ritonavir, Sildenafil, Tacrolimus, Tadalafil, and Warfarin, with data comparing change relative to ambrisentan alone.*

FDA Label Image

Ambrisentan-fig2.jpg (Ambrisentan Fig2)

A chart plotting fold change and 90% confidence intervals for pharmacokinetic parameters (Cmax and AUC) of various interacting drugs including Cyclosporine, Digoxin, Ethinylestradiol, Norethindrone, Mycophenolic acid, Ritonavir, Sildenafil, Desmethylsildenafil, Tadalafil, Warfarin, S-Warfarin, and R-Warfarin. The x-axis represents the change relative to the interacting drug alone, ranging from 0.0 to 3.0.*

FDA Label Image

Ambrisentan-fig3.jpg (Ambrisentan Fig3)

Two line graphs titled ARIES-1 and ARIES-2 display treatment effects over 12 weeks. The y-axes measure distance in meters from -30 to 60, and the x-axes show Baseline, Week 4, Week 8, and Week 12. Different line styles represent placebo and varying ambrisentan dosages. Error bars indicate variability at each time point.*

FDA Label Image

Figure 5 Time To Clinical Worsening (aries-1 And Aries-2) (Ambrisentan Fig4)

Two line graphs labeled ARIES-1 and ARIES-2 showing event-free survival percentages over 12 weeks for ambrisentan versus placebo. Both graphs plot percentage event-free on the y-axis and time in weeks on the x-axis, comparing ambrisentan (solid line) to placebo (dashed line) with numbered at-risk counts below each time point.*

FDA Label Image

Ambrisentan-str.jpg (Ambrisentan Str)

Chemical structure of ambrisentan shown as a 2D molecular diagram, displaying key functional groups including carboxyl, methoxy, and methyl-substituted pyrimidine rings in a connected arrangement.*

FDA Label Image

Label Image (Lbl500907671)

The image shows a white prescription drug bottle label for ambrisentan 5 mg film-coated tablets by A-S Medication Solutions. It indicates a package of 30 tablets, with storage instructions to keep between 68 and 77 degrees Fahrenheit. The label includes NDC 50090-7671-0 and a QR code for dosage information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.